POSTER
Detection of Prostate Cancer BioMarkers by Expression Microarray Analysis of
TransPlex® WTA2 Amplified FFPE Tissue RNA
Ken Heuerman and Brian Ward
Sigma Life Science
Sponsored by Sigma-Aldrich
Published in
September 2010
2010
(p.6)
DOI: 10.2144/000113526
Sponsored,vendor-submitted protocol
Sigma Life Science
Sponsored by Sigma-Aldrich
Published in
September 2010
2010
(p.6)
DOI: 10.2144/000113526
Sponsored,vendor-submitted protocol
The Transplex® Complete Whole Transcriptome Amplification (WTA2) Kit has been
enhanced to effectively amplify damaged RNA and low input amounts of
RNA.Total RNA samples isolated from matched
FFPE(formalin-fixedparaffin-embedded) and frozen prostate tissues (malignant
and normal) were amplified with the Transplex® Complete WTA2 Kit and
analyzed on Agilent Whole Genome expression microarrays. A call rate of >65%
was observed for combined FFPE and frozen expression differentials
(Malignant/Normal), with >90% commonality between the FFPE and frozen
datasets. Amplification reproducibility of experimental replicates was
demonstrated by principal component analysis.Pair-wise comparison of FFPE
malignant and normal expression(p<0.0001) resulted in detection of 66 known
prostate cancer biomarkers. Similar microarray pair-wise analysis of the
original matched FFPE RNAs amplified with the Nugen WT-Ovation™FFPE Kit at
significantly lower level of confidence(p<0.05) revealed only a single array
feature, disallowing a comprehensive comparison with Transplex WTA2.These
results confirm the utility of the Transplex WTA2Kit for amplification of
damaged DNA.
More Information
Do you have question about this Poster? Would you like more information about this poster?
Submit your questions here and BioTechniques will forward your question and contact information from our
database to an expert at
Sigma-Aldrich
Contact Information
3050 Spruce St.
St. Louis
MO
63103
USA
Tel:800-521-8956 or 314-771-5765
Fax:314-771-5757
E-mail:
[email protected]
Poster Categories
